Caladrius Biosciences to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Tuesday, March 22, 2022, at 4:30 p.m. Eastern Time

3 years ago

BASKING RIDGE, N.J., March 15, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage…

Springs Rejuvenation Inc. Establishes Partnership with American Top Team Company

3 years ago

SPRJ Trainer George Mathews, Owner/head coach Roan "Jucao" Carneiro and Dr Charles PereyraAtlanta, GA, March 15, 2022 (GLOBE NEWSWIRE) --…

Mersana Therapeutics to Present an Analysis from the Expansion Cohort of the Phase 1 Trial of Upifitamab Rilsodotin at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer

3 years ago

CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and…

MIMEDX to Present at the Canaccord Genuity Musculoskeletal Conference

3 years ago

MARIETTA, Ga., March 15, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental…

Trusting Heart Blood Center Holds Ribbon Cutting Ceremony for Opening of its Second Platelet Donation Site

3 years ago

Photo 1 Reception at New Trusting Heart Blood Center – Raleigh, North Carolina Photo 2 Exterior of New Trusting Heart…

PepGen Announces Approval by Health Canada of CTA to Begin First in Human Trials of PGN-EDO51 to Treat Duchenne Muscular Dystrophy

3 years ago

Updates on preclinical data and the clinical development plan will be presented at the Muscular Dystrophy Association (MDA) Clinical &…

Extendicare Announces March 2022 Dividend of C$0.04 per Share

3 years ago

MARKHAM, Ontario, March 15, 2022 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has…

First Participants Dosed in Phase 2a Study of Pan-Antiviral Nasal Spray

3 years ago

ENA Respiratory begins influenza challenge study for fast-acting nasal spray INNA-051, designed to boost innate immunity in patients at high…

Neoleukin Therapeutics Announces Appointment of Donna Cochener as General Counsel

3 years ago

SEATTLE, March 15, 2022 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to…

LifeMD to Participate in the KeyBanc Virtual Healthcare Conference

3 years ago

NEW YORK, March 15, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today…